Impact of cytoreductive nephrectomy in patients with metastatic kidney cancer
Cytoreductive nephrectomy is the removal of the tumour to reduce [...]
Treatment of kidney masses in patients with VHL disease
In this video interview, Dr Eric Jonasch from MD Anderson [...]
Approach to selection of first-line treatment for advanced kidney cancer
During this online interview, the approach to selection of first-line [...]
Managing adverse events in kidney cancer patients on immunotherapy/TKI combination treatment
In this video interview, Dr Eric Jonasch from MD Anderson [...]
Probiotic supplements and improves clinical benefit in kidney cancer
This prospective, randomised study in 20 people looked at the [...]
PDIGREE trial: Ipilimumab plus nivolumab with cabozantinib for untreated advanced kidney cancer
During this video interview from UroToday, Dr Tian Zhang from [...]
New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
Safety and efficacy of tivozanib–nivolumab combination in patients with metastatic kidney cancer
In this phase 1b/2 study the researchers looked at a [...]
Cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
In this video interview with Dr Monty Pal from the [...]
Treatment selection for metastatic kidney cancer based on gene expression
The discovery of a reliable biomarker for metastatic renal cell [...]
